In March 2025, the company announced new options for any immediate-to-client offering of its Wegovy weight loss drug. The company recognized a brand new pharmacy, named NovoCare, which would demand clients $499 a month for use of the drug, fewer than fifty percent the cost of the drug via other pharmaceutical distribution networks.[53]Scientific st